In 2018, colorectal cancer was the third-most common diagnosed cancer among both men and women in the U.S., and data indicate that younger adults are increasingly being diagnosed with it. A new research initiative will examine how the microbiome—a collection of trillions of microorganisms throughout the body—affects the development of colorectal cancer. Scientists on the team will also seek out ways to manipulate the microbiome to better prevent and treat colorectal cancer.

In this week's episode, part two of our miniseries on cancer prevention, we're speaking with one of the co-principal investigators of the team, Wendy Garrett, professor of immunology and infectious diseases at Harvard T.H. Chan School of Public Health. Garrett is also on the steering committee of the Zhu Family Center for Global Cancer Prevention. In part one of our miniseries, we spoke to Timothy Rebbeck, the center's director.

Full Transcript: https://hsph.me/microbiome-pod